Generic Drugs: While it could take more than 5 years, eventually patents on GLP-1 drugs will expire, leading to the introduction of generic versions
Wright JW, Kawas LH, Harding JW

WilliamsWells Fargo AdvisorsGreenwood VillageColorado - Denver Area (High Net Worth)$5M$1B$5-50M$3-20MBrett BillsNilsine PartnersGreenwood VillageColorado - Denver Area (High Net Worth)$1M$1.6B$3-200M$2.5-100MDavid LivranMerrill Wealth ManagementDenverColorado - Denver Area (High Net Worth)$500K$861M$1.5-20M$1.5-7.5MTim WilsonMerrill Wealth ManagementGreenwood VillageColorado - Denver Area (High Net Worth)$1M$1.4B$3-50M$1-7MMark GregoryUBS Wealth ManagementCherry CreekColorado - Denver Area (High Net Worth)$2M$1B$5-12M$2-10MAdam LewisWells Fargo AdvisorsDenverColorado - Denver Area (High Net Worth)$250K$477M$1-20M$750K-5MAndy KauthUBS Wealth ManagementDenverColorado - Denver Area (High Net Worth)$1.5M$1B$2.5-20M$2.5-5MDarin HammerschmidtWealthClarityLakewoodColorado - Denver Area (High Net Worth)$500K$468M$2-50M$1-25MCarin WagnerGHP Investment AdvisorsDenverColorado - Denver Area (High Net Worth)$500K$2.8B$4-8M$4-8MDaniel BarotzFocused AlphaDenverColorado - Denver Area (High Net Worth)$500K$566M$3-10M$750K-5MProfile SpotlightBryan AustinLongwise Wealth Partners | Northwestern MutualLakewoodColorado - Denver Area (High Net Worth)$1M$902M$5-70M$1-50MSteve BoorenProsperion Financial AdvisorsGreenwood VillageColorado - Denver Area (High Net Worth)$2M$1.7B$2-6M$3-10MRob GuthrieMerrill Wealth ManagementGreenwood VillageColorado - Denver Area (High Net Worth)$2M$719M$3-8M$2-4MRobert JurkiewiczMerrill Wealth ManagementDenverColorado - Denver Area (High Net Worth)$2M$647M$5-20M$2-20MHolly BarowayStifelDenverColorado - Denver Area (High Net Worth)$1M$650M$2-10M$2-10MBryan KoepfMorgan Stanley Wealth ManagementGreenwood VillageColorado - Denver Area (High Net Worth)$0$1B$1-10M$1-5MMitch HooverMerrill Wealth ManagementDenverColorado - Denver Area (High Net Worth)$10M$3.6B$4-20M$4-15MThomas M

With demand already high for injectable weightmanagement medications, employers faced concerns about coverage
Book an Appointment Send us a note and we'll be in touch within one business day
George Frey/Bloomberg via Getty Images Its hard to turn on the TV, read the news or make it through a conversation without hearing about Ozempic and other drugs like it that belong to a class of medications known as glucagon-like peptide-1 receptor agonists, or GLP-1s